PRG4 and steatosis: Collectively, these studies reinforce the potential of EV proteomics to reflect liver biology and disease progression, and our current findings extend this work by identifying proteins, including AFM, INHBE, COL18A1, and PRG4, that may serve as candidate hepatocyte-derived biomarkers of steatosis in postmenopausal women.